1. Home
  2. CMCO vs PBYI Comparison

CMCO vs PBYI Comparison

Compare CMCO & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

SELL

Current Price

$14.64

Market Cap

483.0M

Sector

Industrials

ML Signal

SELL

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

SELL

Current Price

$9.82

Market Cap

467.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CMCO
PBYI
Founded
1875
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.0M
467.2M
IPO Year
2002
2011

Fundamental Metrics

Financial Performance
Metric
CMCO
PBYI
Price
$14.64
$9.82
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $26.00
N/A
AVG Volume (30 Days)
★ 343.8K
307.6K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 1.86%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.08
Revenue
★ $936,240,000.00
$27,685,000.00
Revenue This Year
$76.00
N/A
Revenue Next Year
$4.04
$1.33
P/E Ratio
★ N/A
$131.50
Revenue Growth
★ 3.27
N/A
52 Week Low
$11.99
$4.58
52 Week High
$24.40
$10.72

Technical Indicators

Market Signals
Indicator
CMCO
PBYI
Relative Strength Index (RSI) 33.80 51.63
Support Level $13.45 $8.90
Resistance Level $15.46 $10.04
Average True Range (ATR) 0.68 0.41
MACD -0.12 0.01
Stochastic Oscillator 3.64 38.13

Price Performance

Historical Comparison
CMCO
PBYI

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a world-wide designer, manufacturer and marketer of intelligent motion solutions for material handling that move the world forward and improve lives by efficiently and ergonomically moving, lifting, positioning and securing materials. Its key products include hoists, crane components, precision conveyor systems, rigging tools, light rail workstations and digital power and motion control systems. These are relevant, professional-grade solutions that solve its customers critical material handling requirements. The company has one operating and reportable segment. It has presence in United State, Germany, Europe, Middle East, and Africa (Excluding Germany), Canada, Asia Pacific, and Latin America. It has majority of sales from United States.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: